A randomized phase II study comparing the sequences of regorafenib (reg) and trifluridine/tipiracil (t/t) after failure of standard therapies in patients (pts) with metastatic colorectal cancer (mCRC

ANNÉE

2024

AUTEURS

Ducreux MP, Ben Abdelghani M, Tougeron D, Bouche O, Viaud J, Khemissa Akouz F, Martin-Babau JF, Bachet JB, Coutzac C, Castanie H, Taieb J, Phelip JM, Fares N, Etchepare N, Botsen D , Mailleux N, Chevrot M,TANGUY , Parzy A

CONGRÈS/REVUE

ESMO GI

ÉTUDE

Localisation

LIEN PUBLICATIONS ASSOCIÉES